December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

0.8801 -0.0170 (-1.89%)
Delayed Quote Updated: 12:59 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
News headline image
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant ↗
Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa. It said that the shot would be... 
Via Benzinga
News headline image
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen ↗
Both vaccine makers still have big hurdles to jump. 
Via The Motley Fool
News headline image
Does This News Make Inovio Pharmaceuticals Stock a Buy? ↗
The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing? 
Via The Motley Fool
News headline image
Why Inovio Stock Is Rising Today ↗
The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate. 
Via The Motley Fool
News headline image
Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript ↗
INO earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News ↗
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S.... 
Via Benzinga
News headline image
Why Shares of Inovio Pharmaceuticals Rallied Today ↗
The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point. 
Via The Motley Fool
News headline image
RBLX Stock Alert: What Is Going on With Roblox Shares Today? ↗
Roblox (RBLX) stock is soaring higher on Tuesday following the release of the company's earnings report for the third quarter of 2021. 
Via InvestorPlace
News headline image
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher ↗
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine. 
Via InvestorPlace
News headline image
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial ↗
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it... 
Via Benzinga
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the... 
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
News headline image
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio ↗
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... 
Via Talk Markets
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
News headline image
Is This The Turning Point for Inovio? ↗
The biotech's streak of bad luck may be about to end, but risks remain. 
Via The Motley Fool
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... 
Via FinancialNewsMedia
News headline image
Is Vaccine Latecomer Inovio Making a Comeback? ↗
Its new plan for phase 3 trials is advancing. 
Via The Motley Fool
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
Via FinancialNewsMedia
News headline image
Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting... 
Via Benzinga
News headline image
Etsy And NetApp Lead The S&P 500 ↗
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Inovio Stock Is Jumping Today ↗
The vaccine maker received some good news from Brazil. 
Via The Motley Fool
News headline image
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading... 
Via Benzinga
News headline image
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-... 
Via Benzinga
News headline image
Why Inovio's Stock Is Trading Higher Today ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the... 
Via Benzinga
News headline image
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money ↗
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
News headline image
Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.